Evidence map›Paper›PMID 20592493›Full record

ArticleCancer biology & therapy2010

New insights into cathepsin D in mammary tissue development and remodeling.

Naira V Margaryan, Dawn A Kirschmann, Alina Lipavsky, Caleb M Bailey, Mary J C Hendrix, Zhila Khalkhali-Ellis

Open access · bronzeAbstract read
In one paragraph

Article in Cancer biology & therapy, 2010. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 13 papers.

0numbers the graph read from it
0cells of the map it votes in
13citing papers in PubMed
0.8field-weighted citation impact, top 24% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

13 citing papers in PubMed, 27 citations in OpenAlex.

  1. Review
  2. Review
  3. Article
  4. Review
  5. Article
  6. Enzymatically active cathepsin D sensitizes breast carcinoma cells to TRAIL.Tumour biology : the journal of the International Society for Oncodevelopmental Biology and Medicine · 2016
    Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Article
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

6 authors at 3 institutions in 3 countries.

Naira V MargaryanChildren's Memorial Research Center, Cancer Biology and Epigenomics Program, Northwestern University Feinberg School of Medicine, Chicago, Illinois USA.
Dawn A Kirschmann
Alina Lipavsky
Caleb M Bailey
Mary J C Hendrix
Zhila Khalkhali-Ellis
Memorial · RUMemorial Medical Center · USNorthwestern University · US

Funding

BIOLOGICAL FUNCTIONS OF MASPINR01CA075681 · NCI · UNIVERSITY OF IOWA · PI HENDRIX, MARY J.C. · 1997 to 2009
$1.7M
NCI NIH HHS CA 75681NCI NIH HHS R01 CA075681
6 · The paper itself

Abstract

Cathepsin D (CatD) is a lysosomal aspartyl endopeptidase originally considered a "house keeping enzyme" involved in the clearance of unwanted proteins. However, recent studies have revealed CatD's involvement in apoptosis and autophagy, thus signifying an important function in the proper development and maintenance of multi-cellular organs. In the mammary gland, matrix degradation and the remodeling process are orchestrated by proteolytic enzymes, but the role of CatD at distinct developmental stages has remained mostly unexplored. Based on our previous studies we sought to address the role of this endopeptidase in mammary gland development and remodeling. By employing a mouse model, we report a previously unidentified participation of CatD in different stages of mammary gland development. Our findings reveal that CatD undergoes distinct protein processing at different stages of mammary gland development, and this customized processing results in differential enzymatic activity (constitutive and low pH activatable) best fitting particular stage(s) of development. In addition, at the onset of involution the N-glycan structure of this endopeptidase switches from a mixed high mannose and hybrid structure to an almost exclusively high mannose type, but reverts back to the original N-glycan composition by day 4 of involution. Our findings illuminate (at least in part) the "raison d'être" for CatD's numerous and highly regulated proteolytic processing steps from the pro-form to the mature enzyme. In the mammary gland, specific cleavage product(s) perform specialized function(s) befitting each stage of remodeling. It is noteworthy that deregulated synthesis, secretion and glycosylation of CatD are hallmarks of cancer progression. Thus, identifying the role of CatD in a dynamic normal tissue undergoing highly regulated cycles of remodeling could provide valuable information illuminating the deregulation of CatD associated with cancer development and metastasis.

Indexed as

AcyltransferasesAnimalsApoptosisAutophagyBasement MembraneCathepsin DCell LineEnzyme-Linked Immunosorbent AssayEpithelial CellsExtracellular MatrixFemaleFluorescent Antibody TechniqueGene Expression Regulation, EnzymologicGlycosylationHumansLactationAcyltransferasesCathepsin DMGAT1 protein, mouseN-AcetylglucosaminyltransferasesRNA, Messenger

Identifiers

PMID20592493
PMCPMC3040969
OpenAlexW2012617221

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.